{"id":"W4404406224","doi":"10.1016/j.ejca.2024.115119","title":"Long-term outcomes among patients who respond within the first year to nivolumab plus ipilimumab or nivolumab monotherapy: A pooled analysis in 935 patients","year":2024,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institutes of Health; Ono Pharmaceutical; National Cancer Institute; National Institute for Health and Care Research; Bristol-Myers Squibb","keywords":"Nivolumab; Ipilimumab; Medicine; Oncology; Internal medicine; Term (time); Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009416279,0.0002845901,0.0006406541,0.0007292364,0.0001016783,0.0001556941,0.0003925294,0.00004657046,0.0007263849],"category_scores_gemma":[0.00009858311,0.0001661044,0.0004727735,0.001377423,0.0001026604,0.0002201757,0.00006301316,0.0004437667,0.00003497054],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007466906,"about_ca_system_score_gemma":0.0003057493,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002263502,"about_ca_topic_score_gemma":0.002620871,"domain_scores_codex":[0.9973239,0.0002910357,0.0009965247,0.0003238759,0.0007490244,0.0003156868],"domain_scores_gemma":[0.9986759,0.00009461813,0.0003857845,0.000395681,0.0002786283,0.0001693191],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01521376,0.0001731788,0.9414897,0.00006057063,0.00310659,0.0003345134,0.005569398,0.0002524805,0.00002831455,0.000001355399,0.003484896,0.03028523],"study_design_scores_gemma":[0.009822411,0.001188646,0.9799083,0.0009866321,0.0008677556,0.000005385634,0.0001779672,0.0001272461,0.00004936806,0.000001451969,0.006651131,0.0002136536],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947082,0.001883656,0.00007540584,0.001534809,0.0008953712,0.0004714184,0.00003253987,0.00002410479,0.0003744553],"genre_scores_gemma":[0.9928438,0.0003825867,0.0000617878,0.001390885,0.0002353877,0.00001016769,0.000006128627,0.00008465043,0.004984628],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03841865,"threshold_uncertainty_score":0.7953405,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01540391577830627,"score_gpt":0.2885488382083229,"score_spread":0.2731449224300167,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}